Business Wire
BusinessNike shares slide back toward their 2014 levels, but Wall Street still sees earnings pressureThe Apex TimesBusinessWalmart U.S. sales review raises fresh concerns as an analyst warns of a worst-case consumer backdropThe Apex TimesBusinessJim Cramer says Target’s turnaround looks real, but he’d wait for a better entry pointThe Apex TimesBusinessNvidia’s reported $7 billion licensing deal points to a dealmaking strategy that avoids classic acquisition scrutinyThe Apex TimesBusinessTesla’s U.S. EV share hits 59%, its highest level since 2023The Apex TimesBusinessModerna and Merck’s mRNA cancer vaccine approach reignites optimism about training the immune systemThe Apex TimesBusinessDeere shares strong fiscal Q3 performance and points to a higher full-year profit outlook as construction and forestry demand remains centralThe Apex TimesBusinessBroadcom Shares Drop as Investors Weigh Google’s Expanded AI Chip Partnership With MarvellThe Apex TimesBusinessMorgan Stanley resets its Nvidia stock outlook ahead of the company’s next earnings releaseThe Apex TimesBusinessMarket screen highlights three U.S.-listed stocks grouped with Moderna’s past surge patternThe Apex TimesBusinessResearch Daily highlights new analyst notes on Dell, Marvell and VerizonThe Apex TimesBusinessNvidia shares extend slide as investors look to upcoming quarter’s results for a turning pointThe Apex TimesBusinessNike shares slide back toward their 2014 levels, but Wall Street still sees earnings pressureThe Apex TimesBusinessWalmart U.S. sales review raises fresh concerns as an analyst warns of a worst-case consumer backdropThe Apex TimesBusinessJim Cramer says Target’s turnaround looks real, but he’d wait for a better entry pointThe Apex TimesBusinessNvidia’s reported $7 billion licensing deal points to a dealmaking strategy that avoids classic acquisition scrutinyThe Apex TimesBusinessTesla’s U.S. EV share hits 59%, its highest level since 2023The Apex TimesBusinessModerna and Merck’s mRNA cancer vaccine approach reignites optimism about training the immune systemThe Apex TimesBusinessDeere shares strong fiscal Q3 performance and points to a higher full-year profit outlook as construction and forestry demand remains centralThe Apex TimesBusinessBroadcom Shares Drop as Investors Weigh Google’s Expanded AI Chip Partnership With MarvellThe Apex TimesBusinessMorgan Stanley resets its Nvidia stock outlook ahead of the company’s next earnings releaseThe Apex TimesBusinessMarket screen highlights three U.S.-listed stocks grouped with Moderna’s past surge patternThe Apex TimesBusinessResearch Daily highlights new analyst notes on Dell, Marvell and VerizonThe Apex TimesBusinessNvidia shares extend slide as investors look to upcoming quarter’s results for a turning pointThe Apex TimesBusinessNike shares slide back toward their 2014 levels, but Wall Street still sees earnings pressureThe Apex TimesBusinessWalmart U.S. sales review raises fresh concerns as an analyst warns of a worst-case consumer backdropThe Apex TimesBusinessJim Cramer says Target’s turnaround looks real, but he’d wait for a better entry pointThe Apex TimesBusinessNvidia’s reported $7 billion licensing deal points to a dealmaking strategy that avoids classic acquisition scrutinyThe Apex TimesBusinessTesla’s U.S. EV share hits 59%, its highest level since 2023The Apex TimesBusinessModerna and Merck’s mRNA cancer vaccine approach reignites optimism about training the immune systemThe Apex TimesBusinessDeere shares strong fiscal Q3 performance and points to a higher full-year profit outlook as construction and forestry demand remains centralThe Apex TimesBusinessBroadcom Shares Drop as Investors Weigh Google’s Expanded AI Chip Partnership With MarvellThe Apex TimesBusinessMorgan Stanley resets its Nvidia stock outlook ahead of the company’s next earnings releaseThe Apex TimesBusinessMarket screen highlights three U.S.-listed stocks grouped with Moderna’s past surge patternThe Apex TimesBusinessResearch Daily highlights new analyst notes on Dell, Marvell and VerizonThe Apex TimesBusinessNvidia shares extend slide as investors look to upcoming quarter’s results for a turning pointThe Apex TimesBusinessNike shares slide back toward their 2014 levels, but Wall Street still sees earnings pressureThe Apex TimesBusinessWalmart U.S. sales review raises fresh concerns as an analyst warns of a worst-case consumer backdropThe Apex TimesBusinessJim Cramer says Target’s turnaround looks real, but he’d wait for a better entry pointThe Apex TimesBusinessNvidia’s reported $7 billion licensing deal points to a dealmaking strategy that avoids classic acquisition scrutinyThe Apex TimesBusinessTesla’s U.S. EV share hits 59%, its highest level since 2023The Apex TimesBusinessModerna and Merck’s mRNA cancer vaccine approach reignites optimism about training the immune systemThe Apex TimesBusinessDeere shares strong fiscal Q3 performance and points to a higher full-year profit outlook as construction and forestry demand remains centralThe Apex TimesBusinessBroadcom Shares Drop as Investors Weigh Google’s Expanded AI Chip Partnership With MarvellThe Apex TimesBusinessMorgan Stanley resets its Nvidia stock outlook ahead of the company’s next earnings releaseThe Apex TimesBusinessMarket screen highlights three U.S.-listed stocks grouped with Moderna’s past surge patternThe Apex TimesBusinessResearch Daily highlights new analyst notes on Dell, Marvell and VerizonThe Apex TimesBusinessNvidia shares extend slide as investors look to upcoming quarter’s results for a turning pointThe Apex Times
Back to front
SpaceX and Tesla back a projected $16.8 billion Terafab chip factory, a leap that could reshape near-term bottlenecks for both
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 21, 5:12 PM EDT

SpaceX and Tesla back a projected $16.8 billion Terafab chip factory, a leap that could reshape near-term bottlenecks for both

A planned joint push dubbed “Terafab” would dwarf the biggest chip-related structures on Earth, underscoring how critical advanced semiconductors have become to rockets, cars, and industrial systems.

3 min readEditor-approved Apex article

Two of Elon Musk’s best-known companies, SpaceX and Tesla, are reportedly moving toward a major semiconductor manufacturing effort that, if realized, would scale far beyond the largest chip-factory buildings seen today. The project is described as a Terafab joint venture with a projected cost of about $16.8 billion and a planned footprint described as roughly five times bigger than the largest building on Earth.

The framing matters because both Tesla and SpaceX depend on high-performance chips for core operations. For Tesla, that includes the compute used in vehicle electronics and driver-assistance systems, along with power and control systems used across production. For SpaceX, advanced chips are central to satellite payloads, launch-related electronics, and the software-defined systems that support mission operations.

Semiconductor capacity, in practice, often becomes a pacing item for hardware companies. Advanced chips, specialized packaging, and manufacturing time can all lag demand, forcing companies to redesign components or accept constraints on production schedules. A large new fabrication effort, even if it takes years to build, is a way to reduce reliance on third-party supply for the most strategic chips.

The report also positions Terafab as a venture that could directly benefit both businesses rather than serving a single end market. If the chip output is shared across multiple product lines, Terafab would function less like a one-off manufacturing bet and more like a strategic supply backbone that can be redirected as internal demand changes.

Market reaction to such announcements often hinges on timing and credibility. The available details describe the size and headline price of the planned facility, but they do not provide the full project schedule, the specific chip process node or technology details, or the share of output intended for each company. Without that, investors and analysts typically cannot determine how quickly the companies would see cost reductions, supply stability, or incremental revenue.

Tesla’s stock, in particular, tends to react to narratives that connect manufacturing inputs to production throughput. If a major internal chip source were eventually available at scale, it could reduce exposure to external wafer and advanced packaging bottlenecks. For SpaceX, the impact would be more indirect in the near term, but could matter to long-run mission performance and satellite or launch hardware availability.

Sector-wide, the story fits a broader shift in which industrial and transportation companies are looking to bring more control to their supply chains for semiconductors. That shift has been especially visible in advanced compute and power-control applications, where software requirements and hardware performance expectations keep rising.

Even with the attention on the project’s magnitude, key information remains undisclosed in the reported item. The companies did not, in the available post, outline financing structure, governance for the joint venture, contracted offtake commitments, final capex disbursement milestones, or the precise manufacturing specifications. Those items can change the effective risk profile substantially from announcement to execution.

Investors and industry watchers will likely focus next on whether any formal agreements are announced, whether regulators receive filings for the facility and permits, and whether Tesla and SpaceX provide timelines that narrow the gap between concept and production. The next hard indicates would be project documentation, supply allocation plans, and evidence of progress toward manufacturing readiness rather than only capital-scale projections.

Why It Matters

  • Semiconductors can act as a bottleneck for production and performance, so new internal capacity could reduce supply constraints over time.
  • A shared chip factory could lower risk for both companies if output is planned around the most strategic, high-demand compute needs.
  • If executed, the scale of Terafab suggests a shift from incremental sourcing changes to longer-run manufacturing control.
  • Near-term market impact is likely limited by missing details such as schedules, manufacturing specs, and how quickly output could reach production use.

Sources

Key Facts

  • The planned effort is described as “Terafab,” a chip-factory joint venture involving SpaceX and Tesla.
  • The project is reported with an estimated cost of about $16.8 billion.
  • The planned facility is characterized as roughly five times bigger than Earth’s largest building.
  • The available reporting frames the venture as materially relevant to both businesses rather than serving one company only.
  • No specific chip process details, output allocation, or construction timeline are provided in the available item.

Autos & Transport Related

Aug 21, 6:42 PM EDT
The Apex Times

Tesla’s U.S. EV share hits 59%, its highest level since 2023

A new look at U.S. electric-vehicle sales shows Tesla holding 59% of the market, a peak not seen since 2023, underscoring how the company’s core EV business remains the anchor of its growth strategy even as it expands into broader initiatives.

Tesla’s U.S. EV share hits 59%, its highest level since 2023
The Apex Times